FindTrial
Sign In

Application of 3D Print Bolus For Nasal NK/T-cell Lymphoma Radiation Therapy

Application of 3D Print Bolus For Nasal NK/T-cell Lymphoma Radiation Therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900028011
Enrollment
Unknown
Registered
2019-12-08
Start date
2019-12-10
Completion date
Unknown
Last updated
2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasal NKT-cell Lymphoma

Interventions

Case group:3D print bolus
Normal group:No intervention

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Nasal NK/T-cell Lymphoma patients who need radiotherapy collected from the cancer radiotherapy clinic of West China Hospital of Sichuan University

Exclusion criteria

Exclusion criteria: Patients whose head scanning image can not meet the requirements of 3D printing bolus production; patients whose other parts of body outside the nasal cavity also need compensation production

Design outcomes

Primary

MeasureTime frame
absorbed dose;HI;CI;—

Countries

China

Contacts

Public ContactZhong Renming

West China Hospital, Sichuan University

zrm_100@163.com+86 18980606513

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026